|
| Heart transplant with myoclonus N: 147 | CABG with myoclonus N: 338 | P value |
| Age (mean ± SD) | 64.8 ± 10.3 | 65.2 ± 14.4 | 0.90 |
| Age ≥65 yrs | 83 (56.8%) | 190 (56.2%) | 0.93 |
| Female | 34 (23.2%) | 77 (23.0%) | 0.98 |
| Medical Comorbidities |
|
|
|
| Diabetes Mellitus | 89 (60.6) | 153 (45.3) | 0.123 |
| Congestive Heart Failure | 24 (16.0) | 0 | - |
| Hypertension | 94 (63.7) | 264 (78.0) | 0.215 |
| Hyperlipidemia | 83 (56.9) | 168 (49.6) | 0.463 |
| Atrial Fibrillation | 9 (6.5) | 131 (38.8) | <0.0001 |
| Renal Failure | 94 (64.0) | 96 (28.4) | 0.0002 |
| Hypercoagulable state | 0 | 103 (30.6) | - |
| Chronic Lung Disease | 19 (13.0) | 84 (0.24) | 0.086 |
| In-hospital complications |
|
|
|
| Acute Kidney Injury | 98 (66.8) | 132 (39.1) | 0.011 |
| Pneumonia | 19 (13.2) | 40 (11.8) | 0.819 |
| Urinary Tract Infection | 4.5 (3.11) | 28 (8.41) | 0.231 |
| Sepsis | 29 (19.8) | 18 (5.55) | 0.103 |
| Outcomes |
|
|
|
| Prolonged length of stay | 83 (56.5) | 275 (81.2) | 0.008 |
| Discharge disposition of alive patients to nursing home | 39 (30.7) | 128 (43.4) | 0.192 |
| In-hospital mortality | 19 (13.5) | 41 (12.3) | 0.87 |